Adoptive immunotherapy shows encouraging benefit on non-small cell lung cancer: a systematic review and meta-analysis

Although adoptive immunotherapy (AIT) is a novel emerging target treatment for non-small cell lung cancer (NSCLC), its actual efficacy remains controversial. In this meta-analysis, we aimed to evaluate the efficacy of AIT for NSCLC. We systematically searched PubMed, the Cochrane Library, EMBASE, Me...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Binghao, Zhang, Wenxiong, Yu, Dongliang, Xu, Jianjun, Wei, Yiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762575/
https://www.ncbi.nlm.nih.gov/pubmed/29348890
http://dx.doi.org/10.18632/oncotarget.19373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762575/
https://www.ncbi.nlm.nih.gov/pubmed/29348890
http://dx.doi.org/10.18632/oncotarget.19373

Ejemplares similares